Heart disease and stroke statistics—2019 update: a report from the American Heart Association
Each year, the American Heart Association (AHA), in conjunction with the National Institutes
of Health and other government agencies, brings together in a single document the most up-…
of Health and other government agencies, brings together in a single document the most up-…
Heart disease and stroke statistics—2018 update: a report from the American Heart Association
…, CW Callaway, AM Chamberlain, AR Chang, S Cheng… - circulation, 2018 - Am Heart Assoc
… ’s My Life Check-Life’s Simple 7 (Figure 1), which include core health behaviors (smoking,
physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and …
physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and …
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and …
[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a …
…, S Cheng, Y Cheng, N Cherciu, CH Chiu, S Cicenas… - The Lancet, 2019 - thelancet.com
Background First-line pembrolizumab monotherapy improves overall and progression-free
survival in patients with untreated metastatic non-small-cell lung cancer with a programmed …
survival in patients with untreated metastatic non-small-cell lung cancer with a programmed …
[HTML][HTML] Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer
…, MJ Hochmair, SF Powell, SYS Cheng… - New England journal …, 2018 - Mass Medical Soc
… All the patients received four cycles of the investigator’s choice of intravenously administered
cisplatin (75 mg per square meter of body-surface area) or carboplatin (area under the …
cisplatin (75 mg per square meter of body-surface area) or carboplatin (area under the …
Metabolite profiles and the risk of developing diabetes
Emerging technologies allow the high-throughput profiling of metabolic status from a blood
specimen (metabolomics). We investigated whether metabolite profiles could predict the …
specimen (metabolomics). We investigated whether metabolite profiles could predict the …
The genome of the mesopolyploid crop species Brassica rapa
We report the annotation and analysis of the draft genome sequence of Brassica rapa accession
Chiifu-401-42, a Chinese cabbage. We modeled 41,174 protein coding genes in the B. …
Chiifu-401-42, a Chinese cabbage. We modeled 41,174 protein coding genes in the B. …
Genome sequence and analysis of the tuber crop potato
Potato (Solanum tuberosum L.) is the world’s most important non-grain food crop and is central
to global food security. It is clonally propagated, highly heterozygous, autotetraploid, and …
to global food security. It is clonally propagated, highly heterozygous, autotetraploid, and …
[HTML][HTML] Global vascular guidelines on the management of chronic limb-threatening ischemia
…, M Bergoeing, M Bjorck, N Chakfé, S Cheng… - European Journal of …, 2019 - Elsevier
Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused …
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused …